Could the drug supply chain be in danger?

The prescription drug supply chain is vulnerable even without a pandemic, as the industry is so dependent on international suppliers like China—a key provider of the raw materials used to make prescription drugs—and India, which is a major producer of generic drugs, according to experts at John Hopkins University. Pharmacy experts are worried since pharmacies typically operate as a “just-in-time” inventory business that rely on continual shipments of drugs to fill their on-demand pharmacy orders, any disruption in the supply chain could pose severe threats. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.